Basic research of new treatment strategy for graft-versus-host disease via tissue stem cell protection
Project/Area Number |
24790977
|
Research Category |
Grant-in-Aid for Young Scientists (B)
|
Allocation Type | Multi-year Fund |
Research Field |
Hematology
|
Research Institution | Kyushu University |
Principal Investigator |
|
Project Period (FY) |
2012-04-01 – 2014-03-31
|
Project Status |
Completed (Fiscal Year 2013)
|
Budget Amount *help |
¥4,160,000 (Direct Cost: ¥3,200,000、Indirect Cost: ¥960,000)
Fiscal Year 2013: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
Fiscal Year 2012: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
|
Keywords | 組織幹細胞 / 腸幹細胞 / 移植片対宿主病 / パネート細胞 / 脂肪前駆細胞 / 脱毛 / GVHD / 造血幹細胞移植 / REGIIIα / 皮膚幹細胞 |
Research Abstract |
The efficacy of allogeneic stem cell transplantation (allo-SCT) is limited by the devastating complication, graft-versus-host disease (GVHD). We evaluated a link between GVHD induced tissue damage and tissue stem cells. We discovered that Paneth cells, which are identified as niche for intestinal stem cells, are targeted by GVHD, resulting in marked reduction in the expression of alfa-defensins. GVHD associated changes in production of antimicrobial peptides including alfa-defensins delivered loss of physiological diversity among the intestinal microflora. We also found the possibilities that pretransplant conditioning regimen damaged adipose precursor cells, which function as skin stem cell niche to drive hair cycling, and the process of adipose precursor cell recovery was inhibited by chronic GVHD development, resulting in alopecia. Therefore, protection of tissue stem cells as well as their niche from GVHD may ameliorate tissue damage and promote tissue regeneration after allo-SCT.
|
Report
(3 results)
Research Products
(41 results)
-
[Journal Article] Comparison of bortezomib, cyclophosphamide, and dexamethasone (VCD) induction with bortezomib and dexamethasone (BD) induction for the newly diagnosed symptomatic multiple myeloma2014
Author(s)
Takashima S, Miyamoto T, Kamimura T, Yoshimoto G, Kato K, Ito Y, Muta T, Matsushima T, Shiratsuchi M, Tanimoto K, Takenaka K, Iwasaki H, Teshima T, Akashi K
-
Journal Title
Int J Myeloma
Volume: 4(1)
Pages: 7-12
URL
Related Report
Peer Reviewed
-
[Journal Article] Comparison of bortezomib, cyclophosphamide, and dexamethasone (VCD) induction with bortezomib and dexamethasone (BD) induction for the newly diagnosed symptomatic multiple myeloma2014
Author(s)
Takashima S, Miyamoto T, Kamimura T, Yoshimoto G, Kato K, Ito Y, Muta T, Matsushima T, Shiratsuchi M, Tanimoto K, Takenaka K, Iwasaki H, Teshima T, Akashi K.
-
Journal Title
Int J Myeloma.
Volume: 4-1
Pages: 7-12
Related Report
Peer Reviewed
-
[Journal Article] The Use of Oral Beclomethasone Dipropionate in the Treatment of Gastrointestinal Graft-versus-host Disease: The Experience of the Fukuoka BMT Group2014
Author(s)
Takashima S, Eto T, Shiratsuchi M, Hidaka M, Mori Y, Kato K, Kamezaki K, Oku S, Henzan H, Takase K, Matsushima T, Takenaka K, Iwasaki H, Miyamoto T, Akashi K, Teshima T
-
Journal Title
Intern Med.
Volume: in press
Related Report
Peer Reviewed
-
[Journal Article] Reciprocal expression of enteric antimicrobial proteins in intestinal graft-versus-host disease.2013
Author(s)
Eriguchi Y, Uryu H, Nakamura K, Shimoji S, Takashima S, Iwasaki H, Miyamoto T, Shimono N, Hashimoto D, Akashi K, Ayabe T, Teshima T.
-
Journal Title
Biol Blood Marrow Transplant
Volume: 19
Issue: 10
Pages: 1525-1529
DOI
NAID
Related Report
Peer Reviewed
-
[Journal Article] Combination of high-dose melphalan and bortezomib as conditioning regimen for autologous peripheral blood stem cell transplantation in multiple myeloma.2013
Author(s)
Miyamoto T, Yoshimoto G, Kamimura T, Muta T, Takashima S, Ito Y, Shiratsuchi M, Choi I, Kato K, Takenaka K, Iwasaki H, Takamatsu Y, Teshima T, Akashi K.
-
Journal Title
Int J Hematol
Volume: 98
Issue: 3
Pages: 337-345
DOI
Related Report
Peer Reviewed
-
-
-
-
[Journal Article] Low incidence of adenovirus hemorrhagic cystitis following autologous hematopoietic stem cell transplantation in the rituximab era.2012
Author(s)
Mori Y, Miyamoto T, Kamezaki K, Kato K, Kikushige Y, Takashima S, Urata S, Shimoda S, Shimono N, Takenaka K, Iwasaki H, Nagafuji K, Teshima T, Akashi K.
-
Journal Title
Am J Hematol.
Volume: 87
Issue: 8
Pages: 828-30
DOI
Related Report
Peer Reviewed
-
-
[Journal Article] The Use of Oral Beclomethasone Dipropionate in the Treatment of Gastrointestinal Graft-versus-host Disease : The Experience of the Fukuoka BMT Group
Author(s)
Takashima S, Eto T, Shiratsuchi M, Hidaka M, Mori Y, Kato K, Kamezaki K, Oku S, Henzan H, Takase K, Matsushima T, Takenaka K, Iwasaki H, Miyamoto T, Akashi K, Teshima T
-
Journal Title
Intern Med
Volume: (In press)
Related Report
Peer Reviewed
-
[Presentation] 同種移植後再発に対してAzacitidine 併用ドナーリンパ球輸注を行い, 非血縁者間同種骨髄移植を実施した急性骨髄性白血病2014
Author(s)
高嶋 秀一郎, 加藤 光次, 林 正康, 浦田 真吾, 菊繁 吉謙, 牟田 毅, 竹中 克斗, 岩崎 浩己, 宮本 敏浩, 豊嶋 崇徳, 赤司 浩一
Organizer
第35回日本造血細胞移植学会
Place of Presentation
金沢
Year and Date
2014-03-09
Related Report
-
-
-
[Presentation] Oral beclomethasone dipropionate for treatment of gastrointestinal graft-versus-host disease : Experience of the Fukuoka BMT group2013
Author(s)
Shuichiro Takashima, Tetsuya Eto, Motoaki Shiratsuchi, Michihiro Hidaka, Yasuo Mori, Koji Kato, Kenjiro Kamezaki, Seido Oku, Hideho Henzan, Ken Takase, Takamitsu Matsushima, Katsuto Takenaka, Hiromi Iwasaki, Toshihiro Miyamoto, Koichi Akashi, and Takanori Teshima
Organizer
第75回日本血液学会 学術集会
Place of Presentation
札幌
Year and Date
2013-10-12
Related Report
-
-
-
[Presentation] Bortezomib, cyclophosphamide and dexamethasone (VCD) induction for symptomatic multiple myeloma2012
Author(s)
Shuichiro Takashima, Toshihiro Miyamoto, Tomohiko Kamimura, Shingo Urata, Yoshikane Kikushuge, Yong Chong, Yoshikiyo Ito, Koji Kato, Kazuki Tanimoto, Katsuto Takenaka, Hiromi Iwasaki, Takanori Teshima, and Koichi Akashi
Organizer
第74回日本血液学会 学術集会
Place of Presentation
京都
Year and Date
2012-10-21
Related Report
-
-
-
-
[Presentation] Oral beclomethasone dipropionate for treatment of gastrointestinal graft-versus-host disease: Experience of the Fukuoka BMT group
Author(s)
Takashima S, Eto T, Shiratsuchi M, Hidaka M, Mori Y, Kato K, Kamezaki K, Oku S, Henzan H, Takase K, Matsushima T, Takenaka K, Iwasaki H, Miyamoto T, Akashi K, Teshima T
Organizer
The 75th Annual Meeting of the Japanese Society of Hematology
Place of Presentation
Sapporo
Related Report
-
[Presentation] Allogeneic stem cell transplantation for t-MDS/AML following chemotherapy for solid cancer
Author(s)
Jinnouchi F, Muta T, Yurino A, Tochigi T, Semba Y, Kusumoto H, Shima T, Takashima S, Kohno K, Yoshimoto G, Yamasaki S, Kato K, Takenaka K, Iwasaki H, Miyamoto T, Ohno Y, Henzan H, Eto T, Akashi K
Organizer
The 75th Annual Meeting of the Japanese Society of Hematology
Place of Presentation
Sapporo
Related Report
-
-
[Presentation] Successful treatment of refractory primary C-ALCL with hematopoietic stem cell transplantation
Author(s)
Yurino A, Yoshimoto G, Takenaka K, Shima T, Takashima T, Kamezaki K, Kato K, Muta T, Iwasaki H, Miyamoto T, Akashi K
Organizer
The 75th Annual Meeting of the Japanese Society of Hematology
Place of Presentation
Sapporo
Related Report
-
[Presentation] Severe cholecystitis induced remission for relapsed AML after allogeneic PBSCT
Author(s)
Semba Y, Yamasaki S, Miyamoto T, Jinnnouchi F, Kikushige Y, Takashima S, Yoshimoto G, Kato K, Muta T, Takenaka K, Iwasaki H, Akashi K
Organizer
The 75th Annual Meeting of the Japanese Society of Hematology
Place of Presentation
Sapporo
Related Report
-
[Presentation] BKV サブタイプ3 型が同種造血幹細胞移植後出血性膀胱炎の発症リスクである:福岡骨髄移植グループ(FBMTG) の検討
Author(s)
加藤光次,宮本 敏浩,江藤義隆,米本孝二,吉田周郎,斉藤統之,平安山英穂,伊藤能清,高嶋秀一郎,菊繁吉謙,牟田毅,竹中克斗,岩崎浩己,上村智彦,衛藤徹也,豊嶋崇徳,下野信行,林純,赤司浩一
Organizer
第35回日本造血細胞移植学会総会
Place of Presentation
金沢
Related Report
-
-
-
-
[Presentation] BK Virus Subtype III Is Associated with Hemorrhagic Cystitis after Allogeneic Hematopoietic Stem Cell Transplantation
Author(s)
Kato K,Miyamoto T,ETO Y,Yonemoto K,Yoshida S,Saito N,Henzan H,Ito Y,Yuda J,Hayashi M,Takashima S, et. al
Organizer
2013 BMT Tandem Meetings
Place of Presentation
Salt Lake City, USA
Related Report
-
[Presentation] Lenalidomide Could Minimize an Engraftment Syndrome After Autologous Hematopoietic Stem Cell Transplantation in Patients with POEMS Syndrome
Author(s)
Yuda J, Kato K, Takenaka K, Hayashi J, Urata S, Takashima S, Kikushige Y, Tanimoto K, Iwasaki H, Miyamoto T, Teshima T, Akashi K
Organizer
2013 BMT Tandem Meetings
Place of Presentation
Salt Lake City, USA
Related Report
-
-
-
[Presentation] BKV subtype is associated with haemorrhagic cystitis after allo-HSCT: Analysis of data from FBMTG
Author(s)
Kato K, Miyamoto T, Eto Y, Yoshida S, Saito N, Henzan H, Ito Y, Oku S, Kuriyama T, Mori Y, Urata S, Takashima S, et al.
Organizer
第74回日本血液学会学術集会
Place of Presentation
京都
Related Report
-
[Presentation] Bortezomib, cyclophosphamide and dexamethasone (VCD) induction for symptomatic multiple myeloma
Author(s)
Takashima S, Miyamoto T, Kamimura T, Urata S, Kikushige Y, Chong Y, Ito Y, Kato K, Tanimoto K, Takenaka K, Iwasaki H, Teshima T, Akashi K
Organizer
第74回日本血液学会学術集会
Place of Presentation
京都
Related Report
-
-
-
-
-